Fairmount Funds Management LLC

Director, Spyre Therapeutics, Inc.; Director, Cogent Biosciences, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$770M

Companies

Latest trade

Jun 23, 2026

Companies

Spyre Therapeutics, Inc.Director −$400M Cogent Biosciences, Inc.Director −$370M

Trades

SYRE Sold 4,684,781 shares at $85.31 $400M Jun 23

COGT Sold 7,000,000 shares at $34.66 $243M Mar 31

COGT Sold 3,500,000 shares at $36.40 $127M Jan 22

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.